DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2002 Sandra Strobl Variation applications within the European Community for a) innovative medicinal products authorised by centralised procedure, b) new medicinal products authorised by mutual recognition procedure ***
2002 Dr. Anja Tischlich Regulatory and economic conditions for clinical trials in children ***
2002 Ngoc Hanh Trieu The Swiss registration system - current development
2002 Dr. Daniela Völker Current Regulatory Issues in the Assessment of Manufacturing of Active Substances ***
2002 Dr. Christian Witt Influence of the EU-enlargement on the procedures for granting marketing authorisations for medicinal products in a single European market ***
2001 Claudia Lydia Abel Haemophilia Conventional Therapy and Gene Therapy related to EU-Guidelines ***
2001 Dr. Beate Ackermann The Internet presentation of national regulatory authorities in Europe and Japan
2001 Dr. Elke Bertram-Neis Orphan Drugs and rare diseases
2001 Dr. Michaela Bleile-Röhrlich Established active substances: Process of registration and regulatory strategy for submissions in the EU ***
2001 Dr. Bettina Doepner The Common Technical Document, Module 3 - Quality, Proposal for adaptation to herbal medicinal products ***
2001 Dr. Susanne Donat Mechanistic considerations on the carcinogenic effects of fibrates ***
2001 Dr. Jan Dütemeyer Information in the Internet about Medicinal Products Provided by Governmental Institutions in Germany, Great Britain and the United States
2001 Karen Frischke The annex to Council Directive 75/318 and its consequences on new and existing marketing authorisations in the EC ***
2001 Dr. Karin Heidenreich Review 2001: The future of the Mutual Recognition Procedure including special aspects of the EU-enlargement ***
2001 Dr. Joachim Heinze Legal Basis of the Parallel Participation of the Principality of Lichtenstein in the European Economic Area and the Customs Union with Switzerland ***
2001 Dr. Klaus Hohenleitner "The quality of the active substance - A look at the different regulatory requirements"
2001 Dr. Alexander Kainz Developing biopharmaceuticals - Regulatory aspects of the safety evaluation of monoclonal antibodies in the United States and in Europe ***
2001 Brigitte Nerl Maintenance of Generic Marketing Authorizations ***
2001 Dr. Carolin Notheis Regulatory requirements concerning the quality of herbal medicinal products under the EU pharmaceutical and national food legislation ***
2001 Dr. Katrin Sauerland The Demarcation of Medical Devices and Medicinal Products in the European Union ***
  • Total: 968